DoD Breast Cancer, Era of Hope Scholar Award | HT9425 23 BCRP EOHS

Opportunity Information: Apply for HT9425 23 BCRP EOHS

The DoD Breast Cancer Era of Hope Scholar Award (funding opportunity number HT9425 23 BCRP EOHS) is a discretionary Department of Defense research funding opportunity managed by the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is offered as either a grant or a cooperative agreement under CFDA 12.420, within the Science and Technology and other Research and Development category. The program is designed to back early-career investigators who have already shown unusual promise and momentum, with the goal of accelerating truly original leaders who can drive meaningful change in breast cancer research.

What makes this award distinctive is that it is centered on the person rather than on a single, narrowly defined project. The intent is to identify exceptionally talented scientists who stand out as the "best and brightest" because of their creativity, vision, innovation, and productivity. Reviewers are looking for clear evidence that the Principal Investigator can think beyond standard approaches in their field, challenge prevailing assumptions, and articulate a bold direction that could shift how the breast cancer field thinks or operates. The application is expected to present a compelling scientific vision that pushes past tradition and conventional dogma, emphasizing the unique contribution the PI is positioned to make toward ending breast cancer.

The opportunity is open to a wide range of applicants (listed as unrestricted, meaning any entity type may apply unless additional eligibility language in the full announcement narrows it). Importantly, direct prior experience specifically in breast cancer research is not required. The program explicitly encourages strong investigators from other disciplines to bring fresh concepts, tools, or perspectives into breast cancer, as long as the proposed work is clearly focused on breast cancer. At the same time, the PI must make a serious commitment of effort: a minimum of 25 percent level of time and effort during the award period must be devoted to conducting breast cancer research supported by this award.

The award also places heavy emphasis on collaboration and meaningful stakeholder involvement. Applicants are encouraged to build a research team with the right expertise and partnerships to accomplish the research goals, reflecting the program expectation that successful scholars can form effective collaborations. A specific required feature is the inclusion of two or more breast cancer consumer advocates as part of the PI's research team. These advocates must be lay representatives who have been diagnosed with breast cancer and who are actively involved in a breast cancer advocacy organization. Their participation must be independent of their employment, and they cannot be employees of any organization that is participating in the application. The program expects these advocates to be knowledgeable about current breast cancer issues and to have sufficient background and/or training in breast cancer research to contribute in a substantive way. Their role is to provide objective input throughout the research effort, with particular attention to relevance and potential impact for people who have breast cancer or who are at risk.

Key administrative details from the posted source include a creation date of February 6, 2023, and an original closing date of April 11, 2023. The opportunity listed an expectation of one award. The posted award ceiling is shown as 0, which typically indicates that the ceiling is not stated in the summary field and would need to be confirmed in the full funding announcement or associated program guidance.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Breast Cancer, Era of Hope Scholar Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Feb 06, 2023.
• Applicants must submit their applications by Apr 11, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for HT9425 23 BCRP EOHS

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: